Lei Xia

460 total citations
13 papers, 329 citations indexed

About

Lei Xia is a scholar working on Cancer Research, Molecular Biology and Oncology. According to data from OpenAlex, Lei Xia has authored 13 papers receiving a total of 329 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Cancer Research, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Lei Xia's work include Cancer, Lipids, and Metabolism (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and MicroRNA in disease regulation (2 papers). Lei Xia is often cited by papers focused on Cancer, Lipids, and Metabolism (3 papers), Ovarian cancer diagnosis and treatment (2 papers) and MicroRNA in disease regulation (2 papers). Lei Xia collaborates with scholars based in China. Lei Xia's co-authors include Yi Luo, Ning Xu, Feng Xue, Qiang Xia, Conghuan Shen, Hairong Zhang, Jianjun Zhang, Yanan Zhang, Jìng Guo and Bin Jia and has published in prestigious journals such as Scientific Reports, Biochemical and Biophysical Research Communications and Journal of Medicinal Chemistry.

In The Last Decade

Lei Xia

11 papers receiving 325 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Lei Xia China 9 218 174 45 37 33 13 329
Maghawry Hegazy Egypt 11 222 1.0× 202 1.2× 47 1.0× 32 0.9× 28 0.8× 17 373
Mahmoud Mohamed Mokhtar Egypt 9 211 1.0× 201 1.2× 41 0.9× 31 0.8× 24 0.7× 14 333
Amirhosein Maharati Iran 9 217 1.0× 158 0.9× 56 1.2× 20 0.5× 26 0.8× 24 308
Mehdi Manoochehri Iran 13 226 1.0× 132 0.8× 79 1.8× 34 0.9× 31 0.9× 23 384
Jiarong Cai China 13 256 1.2× 142 0.8× 38 0.8× 40 1.1× 50 1.5× 28 415
Farzad Rahmani Iran 10 229 1.1× 148 0.9× 66 1.5× 18 0.5× 30 0.9× 15 375
Yun Su China 12 176 0.8× 78 0.4× 49 1.1× 33 0.9× 19 0.6× 27 345
Athanasios Pagkalos Greece 7 202 0.9× 102 0.6× 62 1.4× 19 0.5× 26 0.8× 10 308

Countries citing papers authored by Lei Xia

Since Specialization
Citations

This map shows the geographic impact of Lei Xia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lei Xia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lei Xia more than expected).

Fields of papers citing papers by Lei Xia

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lei Xia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lei Xia. The network helps show where Lei Xia may publish in the future.

Co-authorship network of co-authors of Lei Xia

This figure shows the co-authorship network connecting the top 25 collaborators of Lei Xia. A scholar is included among the top collaborators of Lei Xia based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lei Xia. Lei Xia is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

13 of 13 papers shown
1.
Zhang, Shuai, Yanjie Huang, Xueli Zhang, et al.. (2025). Capsaicin inhibits porcine enteric coronaviruses replication through blocking TRPV4-mediated calcium ion influx. International Journal of Biological Macromolecules. 302. 140495–140495. 1 indexed citations
3.
Zhu, Lin, et al.. (2024). Drug repositioning and ovarian cancer, a study based on Mendelian randomisation analysis. Frontiers in Oncology. 14. 1376515–1376515. 1 indexed citations
4.
Xia, Lei, Shichao Ding, Xuezhen Wang, et al.. (2023). Advances in ovarian cancer treatment using a combination of statins with other drugs. Frontiers in Pharmacology. 13. 1048484–1048484. 10 indexed citations
5.
Zhang, Yanan, et al.. (2022). Molecular Mechanism of β-Sitosterol and its Derivatives in Tumor Progression. Frontiers in Oncology. 12. 926975–926975. 56 indexed citations
6.
Hu, Yunfeng, Lei Xia, Hong Zhao, et al.. (2020). LINC00641/miR-582-5p mediate oxaliplatin resistance by activating autophagy in gastric adenocarcinoma. Scientific Reports. 10(1). 14981–14981. 30 indexed citations
7.
Xia, Lei, Jian Sun, Shaowei Xie, et al.. (2020). PRKAR2B‐HIF‐1α loop promotes aerobic glycolysis and tumour growth in prostate cancer. Cell Proliferation. 53(11). e12918–e12918. 45 indexed citations
8.
Xia, Lei, Jìng Guo, Yuan Wang, et al.. (2020). Inhibition of endometrial carcinoma by Kaempferol is interceded through apoptosis induction, G2/M phase cell cycle arrest, suppression of cell invasion and upregulation of m-TOR/PI3K signalling pathway.. PubMed. 24(4). 1555–1561. 24 indexed citations
9.
Chen, Lili, Jinyang Gu, Yihan Qian, et al.. (2019). Deletion of C-C Motif Chemokine Ligand 5 Worsens Invariant Natural Killer T-Cell–Mediated Hepatitis via Compensatory Up-regulation of CXCR2–Related Chemokine Activity. Cellular and Molecular Gastroenterology and Hepatology. 7(3). 623–639. 14 indexed citations
10.
Jia, Bin, Lei Xia, & Fang Cao. (2018). The role of miR-766-5p in cell migration and invasion in colorectal cancer. Experimental and Therapeutic Medicine. 15(3). 2569–2574. 19 indexed citations
11.
Shang, Wenjun, Lei Xia, Hongxin Zhang, et al.. (2013). Opposing functions of PLAG1 in pleomorphic adenoma: a microarray analysis of PLAG1 transgenic mice. Biotechnology Letters. 35(9). 1377–1385. 17 indexed citations
13.
Xu, Ning, Conghuan Shen, Yi Luo, et al.. (2012). Upregulated miR-130a increases drug resistance by regulating RUNX3 and Wnt signaling in cisplatin-treated HCC cell. Biochemical and Biophysical Research Communications. 425(2). 468–472. 112 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026